The correct classification: Pure GLP-1 agonists: exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, efpeglenatide, orforglipron Dual GIP/GLP-1 agonists: tirzepatide Triple agonists (GIP/GLP-1/glucagon): retatrutide Retatrutide, approved in early 2026, adds glucagon receptor agonism to the dual GIP/GLP-1 mechanism
Bodnaruc et al 2016), compared to the GLP-1 medications with a half-life of 7 days
How It Works Just mention your GLP1 medication at your next visit or call/text us
Which medication is better for weight loss
Clinically, several GLP-1 RAs are approved or under study for obesity
That said, achieving a healthier weight before pregnancy improves virtually every pregnancy outcome measure